학술논문
179P Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) monotherapy in US clinical practice.
Document Type
Article
Author
Source
Subject
*NON-small-cell lung carcinoma
Language
ISSN
0923-7534